scispace - formally typeset
J

Jun Zhang

Researcher at Center for Drug Evaluation and Research

Publications -  83
Citations -  3369

Jun Zhang is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Nephrotoxicity & Cardiotoxicity. The author has an hindex of 32, co-authored 74 publications receiving 3191 citations. Previous affiliations of Jun Zhang include National Institutes of Health & Food and Drug Administration.

Papers
More filters
Journal ArticleDOI

Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases.

TL;DR: The frequent finding of intraluminal fibrosis and the frequent peribronchiolar location of PLCG lesions are consistent with the concept that in adults this disorder is associated with an abnormal response to cigarette smoke.
Journal ArticleDOI

Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium

TL;DR: Urinary Kim- 1 and kidney Kim-1/Havcr1 expression appear to be sensitive and tissue-specific biomarkers that will improve detection of early acute kidney injury following exposure to nephrotoxic chemicals and drugs.
Journal ArticleDOI

Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by Doxorubicin

TL;DR: Measurements of serum levels of cardiac troponin-T (cTnT) seem to provide a sensitive means for assessing the early cardiotoxicity of doxorubicin.
Journal Article

Use of Cardiac Troponin T Levels as an Indicator of Doxorubicin-induced Cardiotoxicity

TL;DR: Monitoring serum levels of cardiac troponin T can detect doxorubicin-induced myocyte damage in SHR and may prove useful for the noninvasive evaluation of this toxicity in humans.
Journal ArticleDOI

Doxorubicin-induced Apoptosis in Spontaneously Hypertensive Rats: Differential Effects in Heart, Kidney and Intestine, and Inhibition by ICRF-187☆

TL;DR: The data support the concept that the chronic cardiomyopathy induced by doxorubicin is not mediated by apoptosis of the cardiac myocytes, as well as showing that significant toxicity in the heart, kidneys and intestine in association with apoptosis in epithelial cells of the intestinal mucosa and renal tubules is induced.